MedTrace Logo

PRP Use in Diabetic Patients Undergoing Cesarean Section

NCT03602950 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-07-27

No results posted yet for this study

Summary

this study will investigate the effectiveness of PRP in wound healing among diabetic patients undergoing elective cesarean sections

Conditions

  • Diabetes, Gestational
  • Wound Complication

Interventions

BIOLOGICAL

PRP

autologous PRP will be injected subcutaneously before skin closure at time of elective CS

Sponsors & Collaborators

  • Minia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2019-02-28
Completion
2019-02-28
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03602950 on ClinicalTrials.gov